Mr. Miller possesses more than 20 years of experience in business development, sales and marketing within the medical device industry. He has served as a senior executive in large public companies — including Intuitive Surgical and United States Surgical Corporation — as well as in privately held, venture-financed start-ups that include Baxano® and Optimize, Inc. Mr. Miller received a bachelor’s degree in health sciences as well as a master’s degree in applied physiology from Ohio State University. He is a named inventor on 19 published patents for medical device applications.
Mr. Lockard brings to Microfabrica over 25 years of management experience in operations and product development. He is a veteran of the 3D printing industry, having held senior management positions in manufacturing, operations and R&D. At 3D Systems, Mr. Lockard contributed to the development of the world’s first commercial 3D printer and led the team that developed multi-jet modeling, the technology that first brought 3D printing into the office environment. He is a named inventor on 49 patents in the fields of additive manufacturing and microfabrication.
Mr. Frodis was a member of the team that founded Microfabrica in 2000. As engineering manager and later director of R&D, Mr. Frodis led the effort to develop and implement the customized equipment used in Microfabrica’s unique manufacturing process. Prior to joining Microfabrica, Mr. Frodis worked as an engineer and researcher at the University of Southern California and was a key contributor to the technology that led to the creation of Microfabrica. Before this, Mr. Frodis’ career focused on automation and machine design after receiving a bachelor’s of science degree in mechanical engineering from the University of Waterloo in Canada. He holds several patents in the field of microfabrication.
Mr. Chen brings Microfabrica a wealth of experience in micro-device design from the MEMS world. Prior to joining Microfabrica, he worked at OMM Inc., where he was a member of the original team that delivered the first qualified MEMS optical switch to the commercial market, and at Lucas Varity Novasensor (currently GE Industrial Systems), where he developed new MEMS products. Mr. Chen received his bachelor’s of science from the University of Illinois at Champaign/Urbana and his master’s of science at the University of California, Los Angeles, both in electrical engineering. He is a named inventor on more than 20 patents and has authored 12 technical publications in MEMS fabrication and design.
Mr. Schmitz brings over 20 years of experience developing and building machines and high-precision tools at both the R&D and commercial levels. He has led many diverse and challenging projects in the fields of process control, automation, handheld electronics, display technology, printing technology and medical devices. His areas of discipline include complex mechanism design, electronic instrumentation, system analysis, high-precision tooling and process development. He is a named inventor on patents in several fields, from printing technology and industrial equipment to medical devices. He is currently leading Microfabrica’s initiative to develop minimally invasive surgical tools and expanding the company’s capabilities in design and integration methodology for next-generation components and assemblies.
Mr. Smalley has been developing and managing high-technology IP portfolios for more than 25 years. He joined 3D Systems, the company that pioneered 3D printing, shortly after the company was founded. After an initial stint in R&D, he established and managed the company’s IP program, developing and defending a global patent portfolio. After leaving 3D Systems, he established and managed an intellectual property program for Medical Research Group prior to its acquisition by Medtronic®. Mr. Smalley is registered to practice before the United States Patent and Trademark Office and holds a bachelor's of science from California Polytechnic University, Pomona, and an master's of science from California State University, Los Angeles, both in physics.
Mr. Patz brings 15 years of corporate finance and auditing experience to Microfabrica. He has a background in both public and corporate accounting, specializing in manufacturing analytics and governance. Prior to joining Microfabrica, Mr. Patz oversaw finance and administration at AAMP Global®, a leading manufacturer of automotive accessories. Mr. Patz holds a bachelor's of science in Communications from Florida State University and a bachelor's of science in Accounting from the University of South Florida and is a licensed CPA.
Mr. Chen is currently a general and founding partner of Medenovo, LLC, a private investment firm focused on medical devices. He is currently the CEO of SPIWay®, LLC, a neuroendoscopy company, and the CEO of Fresca Medical®, a sleep apnea company. Previously, he was founder and CEO of USGI Medical®, which develops technologies to enable incisionless surgery. Prior to USGI, Mr. Chen was a venture partner and entrepreneur-in-residence with Alta Partners, a leading life science venture capital firm. Before Alta Partners, he spent seven years at Applied Medical®, including as general manager of the cardiovascular and urology operating divisions and as senior vice president of corporate operations and international distribution. Earlier in his career, Mr. Chen was founder and CEO of BioFlex® Inc. and Kinesys® Inc., both medical device start-ups in orthopedic knee orthotics, and held various positions at Procter & Gamble. He received a bachelor’s of science degree in mechanical engineering from Cornell University and a master’s of business administration from the Anderson School at University of California, Los Angeles. In addition, Mr. Chen holds 14 U.S. and two international patents and is a member of the board of trustees of the Pacific Ridge School.
Philip “Flip” Gianos has been part of InterWest’s IT team since 1982. With a background in engineering, he has invested in multiple areas of information technology, including semiconductors, computing and networking equipment and infrastructure and applications software. He is former chairman of the board of Xilinx® (XLNX), a publicly held company, and is also a board member of several privately held companies, including Pelican Imaging and Microfabrica. Mr. Gianos also serves on the advisory board of Storm Ventures® II, and is a past president of the Western Association of Venture Capitalists. Prior to joining InterWest, Mr. Gianos was with IBM® for eight years in engineering management. He managed both chip design and systems integration for several IBM office automation products. Mr. Gianos earned his master’s in business administration from Harvard University and received his master’s of science degree and bachelor’s of science degree in electrical engineering from Stanford University. He has one international and two U.S. patents.
Mr. Miller possesses more than 20 years of experience in business development, sales and marketing within the medical device industry. He has served as a senior executive in large public companies — including Intuitive Surgical, United States Surgical Corporation and Johnson & Johnson — as well as in privately held, venture-financed start-ups that include Baxano and Optimize, Inc. Mr. Miller holds a a bachelor’s degree in health sciences and a master’s degree in applied physiology from Ohio State University.
Kevin Wasserstein specializes in investing and building medical device companies at Versant®. His work with entrepreneurs spans the earliest seed or concept stage of development through the entire life cycle of the company.
Mr. Wasserstein has more than 18 years of venture capital and operating experience in medical device and high-technology companies and currently serves, or has served, in board or advisory roles with companies which include: Acclarent® (acquired: Johnson & Johnson), Autonomic Technologies, Respicardia®, LipoSonix® (acquired: Medicis®), Lutonix®, Microfabrica, NeoGuide Systems® (acquired: Intuitive Surgical), Rox Medical, Second Sight Medical, St. Francis Medical® (acquired: Kyphon®) and The Innovation Factory. In addition, he serves as a member of AdvaMed’s National Venture Capital Advisory Board and MDMA’s Venture Capital Advisory Group.
Before joining Versant in 2002, Mr. Wasserstein held a variety of marketing and business development roles at Guidant Corporation. Most recently he served as head of marketing in Guidant’s Cardiac Surgery Group, where he led the group’s product/market development and launch initiatives. In Guidant’s Peripheral and Carotid Group, Mr. Wasserstein developed and launched several first-generation stent and embolic protection devices while leading the carotid stent program’s marketing activities. Previously, in Guidant’s Compass Business Development Group, Mr. Wasserstein’s responsibilities included acquisition, licensing and investment with both private and public medical device companies and corporate strategy. His operational experience also includes business development at Heartstream and engineering design and engineering management at Hughes Aircraft Company.
Mr. Wasserstein holds both bachelor’s and master’s degrees in mechanical engineering, specializing in product design, as well as a master’s in business administration, all from Stanford University.
Warren Packard is a venture partner at Draper Fisher Jurvetson (DFJ). He leads the firm’s investments in BinOptics, Hola!, Microfabrica, Primet Precision Materials and YeePay. He is also the founder and CEO of Thuuz®, a consumer platform for real-time sports discovery and tune-in. Mr. Packard also led DFJ’s investments in Direct Hit® (IACI), Feedburner® (GOOG), Fogdog Sports (EBAY), SeaMicro (AMD), TicketsNow® (LYV) and Xfire® (VIAB). Prior to joining DFJ, Warren co-founded Angara, an eMarketing infrastructure company that merged with Personify. Prior to Angara, he was an associate at Institutional Venture Partners®. Before IVP, he was a senior principal engineer at Baxter International. Warren received his bachelor’s of science, master’s of science and master’s of business administration degrees from Stanford University.
Joining Rambus® in mid-2012 as president and CEO, Dr. Ron Black has fostered a more open and collaborative environment at Rambus®. With over 20 years of experience managing businesses and running companies in global semiconductor and mobile markets, Ron brings an entrepreneurial spirit to Microfabrica and provides the overall vision and leadership necessary to drive future growth. Before joining Rambus®, Dr. Black was the chief executive officer for MobiWire (formerly Sagem Wireless, UPEK, which later merged with AuthenTec®) and Wavecom®, a publicly traded French wireless solutions company. Ron has also served as executive vice president of the Client Systems Group at Agere Systems and has held a number of senior executive roles at other companies, including Motorola® and IBM® Microelectronics.
Ron holds a bachelor’s degree, a master’s and a PhD in materials science and engineering from Cornell University.
Michael Sweeney is a pioneer in the medical device field who went on to become a successful venture capitalist. In the spring of 2011, he retired from Interwest Partners, where he was part of the medical device team for over a decade. He has more than 30 years of experience in the field of cardiovascular devices. He was chairman of Nanostim® Inc., founding CEO of Epicor® Medical, co-founder of Ventritex Inc. and executive vice president of the Cardiac Rhythm Management Division of St. Jude Medical after the merger of St. Jude and Ventritex. He is also a member of the board of trustees of the Leukemia & Lymphoma Society, Silicon Valley/Monterey Bay Chapter.